3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now

Source Motley_fool

Key Points

  • PepsiCo, AT&T, and Pfizer are blue chip dividend stocks that offer high yields.

  • Their valuations are incredibly modest when compared to the average S&P 500 stock.

  • For dividend investors, they can offer a good mix of value and stable dividend income.

  • 10 stocks we like better than Pfizer ›

If you have $1,000 that you can afford to invest in the stock market, dividend stocks can help make the most of your money, specifically those that are trading at low valuations. While buying Nvidia and investing in hot tech stocks can be alluring, they can also be volatile investments. You can set yourself up for safer returns by targeting much more reasonably priced options instead.

Three excellent dividend stocks that can make for more practical investments right now include PepsiCo (NASDAQ: PEP), AT&T (NYSE: T), and Pfizer (NYSE: PFE). Let's take a close look at these businesses and why these stocks look undervalued today.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

A person flipping through dollar bills.

Image source: Getty Images.

PepsiCo

PepsiCo is a leader in the soft drink and snack market. Although it hasn't generated much growth of late, this is still a highly stable company to invest in. In each of the past three years, its revenue has been in excess of $90 billion, and earnings have been north of $8 billion.

This is also the 54th consecutive year that the company has increased its payout, which puts it in the category of a Dividend King. Not many stocks belong to the illustrious club, which features many of the safest income stocks to own. At 4.2%, PepsiCo also already offers a fairly high yield as it is; it's four times that of the S&P 500 average, which is just over 1%.

While PepsiCo's stock has declined this year, it's an intriguing option to hold on to for the long term, given the value it possesses. Currently, it's trading at a forward price-to-earnings (P/E) multiple of 16, which is based on analysts' expectations of its future earnings.

AT&T

Another excellent dividend stock to consider is AT&T. The telecom giant pays 4.5%, which is an even higher payout than PepsiCo. While the company hasn't raised its dividend in years, with AT&T's financials looking strong of late, it may only be a matter of time before it gets back to growing its payout. This year, the company projects its free cash flow to total at least $18 billion, which is far higher than the roughly $8.2 billion that it issues in dividends over the course of 12 months.

At a forward P/E of just 11, the stock is incredibly cheap when compared to the average S&P 500 stock, which trades at 22 times its expected future earnings. With some great value and a high dividend, AT&T looks to be an underrated buy right now. This is a low-volatility investment you can safely hold on to, even amid uncertainty in the markets.

Pfizer

Arguably, one of the best dividend stocks to own right now is Pfizer. At 6.7%, it's hard to find a payout this high without taking on high risk. The stock's payout ratio is over 100%, which is likely to spook investors, but that doesn't tell the whole story. This past year, the company incurred not only one-time acquisition-related expenses but also restructuring costs as it made its operations leaner and more efficient. Without those items, its financials would look much better, and the dividend would appear more sustainable.

Investors are, however, also concerned about what lies ahead for Pfizer due to patent cliffs around multiple drugs, which could weigh on its top line and thus result in an even worse bottom line. But with investments into growing its pipeline and adding valuable assets to expand its growth opportunities (hence the acquisitions), I believe the company is doing what is necessary to combat the challenges ahead.

While its results remain stable right now, investors may be looking for further proof that the business is on the right track before buying the healthcare stock. But with it trading at a forward P/E of just under nine, there's some solid margin of safety that comes with this investment, which can make it worth the risk.

Should you buy stock in Pfizer right now?

Before you buy stock in Pfizer, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $449,393!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,366,006!*

Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 212% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of June 3, 2026.

David Jagielski, CPA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia and Pfizer. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Bitcoin Price In Freefall As Panic Sweeps Through The MarketBitcoin price started a fresh decline below the $70,000 zone. BTC is consolidating and might continue to move down if it dips below $66,000. Bitcoin failed to stay above $70,500 and extended losses.
Author  NewsBTC
18 hours ago
Bitcoin price started a fresh decline below the $70,000 zone. BTC is consolidating and might continue to move down if it dips below $66,000. Bitcoin failed to stay above $70,500 and extended losses.
placeholder
Gold replaces US Treasuries as top global reserve asset, latest ECB report saysA recent report published by the European Central Bank today has stated that central banks globally now hold more gold than US government bonds and treasuries in their reserves for the very first time. Geopolitical tensions, concerns over a risk of sanctions, and a growing desire among some countries to lessen their exposure to dollar-denominated...
Author  Cryptopolitan
18 hours ago
A recent report published by the European Central Bank today has stated that central banks globally now hold more gold than US government bonds and treasuries in their reserves for the very first time. Geopolitical tensions, concerns over a risk of sanctions, and a growing desire among some countries to lessen their exposure to dollar-denominated...
placeholder
Crypto Crash Wipes Out 7% in 24 Hours: What’s Next?The total crypto market capitalization has fallen sharply to $2.32 trillion. The decline has wiped out roughly 17% of the market value in less than three weeks.Bitcoin (BTC) trades near $67,400, down
Author  Beincrypto
18 hours ago
The total crypto market capitalization has fallen sharply to $2.32 trillion. The decline has wiped out roughly 17% of the market value in less than three weeks.Bitcoin (BTC) trades near $67,400, down
placeholder
Google Shares Sink as AI Boom Forces Alphabet to Go Back on Strategy Critical to its StockGoogle stock fell after parent Alphabet (GOOGL) announced an $80 billion equity raise to fund artificial intelligence (AI) infrastructure. The move reverses years of buybacks that steadily shrunk its
Author  Beincrypto
18 hours ago
Google stock fell after parent Alphabet (GOOGL) announced an $80 billion equity raise to fund artificial intelligence (AI) infrastructure. The move reverses years of buybacks that steadily shrunk its
placeholder
Experts Warn Bitcoin Has a MicroStrategy Problem as BTC and MSTR Stock SinkBitcoin (BTC) and MicroStrategy (MSTR) stock plunged on Tuesday after the company disclosed its first BTC sale in 41 months. The move reignited debate over how much the asset depends on one corporate
Author  Beincrypto
18 hours ago
Bitcoin (BTC) and MicroStrategy (MSTR) stock plunged on Tuesday after the company disclosed its first BTC sale in 41 months. The move reignited debate over how much the asset depends on one corporate
goTop
quote